Clinical Trial Update: Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Rituximab, Carmustine, Cytarabine, Etoposide, & Melphalan with stem cell transplantation for lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Carmustine (carmustine)
• Etoposide (Etoposide)
• Melphalan (Melphalan)
• Rituximab (rituximab)
• Stem cell transplantation

Snippet

Sponsor: University of Nebraska | Conditions: Lymphoma | Phase 2 | Status: COMPLETED